Thalia psychotherapy secures strategic funding to scale mental health access in Africa

Mercy Mwende, Thalia Psychotherapy chief operations officer(COO) and Dennis Mwangi, managing partner at Thalia Psychotherapy. [Courtesy]

Thalia Psychotherapy has received a strategic investment from the Health Innovation Exchange (HiEx), marking its second institutional backer after Vilgro Africa.

The funding, backed by the Reckitt Catalyst initiative, will accelerate Thalia’s mission to commercialise mental health care across the continent.

The undisclosed investment highlights growing investor confidence in Thalia’s model, which positions mental health not just as a social imperative, but a viable and scalable market opportunity.

“Mental health is one of the last frontiers in Africa’s healthcare transformation,” said Wanjiku Kimani, Portfolio and Program Manager at HiEx.“We invested in Thalia because they are building a commercially sustainable mental health system that works—from the rural mother to the institutional investor.”

Despite growing awareness, mental health in Africa remains drastically underfunded. The World Health Organisation (WHO) estimates that one in four people globally will experience a mental health condition in their lifetime.

 Yet, Africa has just one mental health professional for every 100,000 people, compared to over 70 in high-income countries. In many African nations, mental health receives less than 1 percent of national health budgets.

Thalia aims to close these gaps with innovative, tech-driven strategies. The startup has already screened more than 2.7 million people for mental health needs and established Africa’s largest network of over 6,000 therapists.

Its services are now integrated into more than 4,000 health facilities across six African countries.

By leveraging AI-powered screening tools and digital platforms, Thalia offers cost-effective care, early detection, and broader access—critical in a region where healthcare systems face immense financial and resource constraints.

“This isn’t about charity—it’s about changing the economics of care,” said Dennis Mwangi, Managing Partner at Thalia Psychotherapy.“We’re proving that investing in mental health generates returns—financially, socially, and systemically.”

A key pillar of Thalia’s strategy is unlocking local capital. The company is pioneering results-based financing structures that allow African pension funds to invest in health while earning market-rate returns. This model aims to lower future public health costs linked to untreated mental health conditions.

“Thalia’s model offers dual returns—strong economic potential and measurable health impact. It’s the kind of investment we need more of in African healthcare,” added Ms Kimani.

The HiEx investment follows a wave of recognition for Thalia, including being named a "Startup to Watch" by Bloomberg and winning the Africa HealthTech Grand Prize at VivaTech 2024.